🚀 VC round data is live in beta, check it out!
Allianca Saude Valuation Multiples
Discover revenue and EBITDA valuation multiples for Allianca Saude and similar public comparables like Devyser Diagnostics, Nano X Imaging, Airdoc, EKF Diagnostics and more.
Allianca Saude Overview
About Allianca Saude
Allianca Saude e Participacoes SA formerly Centro de Imagem Diagnosticos SA - Alliar is a diagnostic imaging company consisting of MRI machines, CT scanners and ultrasound machines. Its products include diagnostic medicine, diagnostic imaging and clinical analysis. The company is also engaged in the import of medical and hospital equipment, diagnosis kits, and related goods; Providing health consulting, advisory, courses and lectures.
Founded
2011
HQ
Employees
N/A
Website
Financials (FY)
EV
$266M
Allianca Saude Financials
Allianca Saude reported last fiscal year revenue of $236M and EBITDA of $36M.
In the same fiscal year, Allianca Saude generated $69M in gross profit, $36M in EBITDA, and had net loss of ($25M).
Allianca Saude P&L
In the most recent fiscal year, Allianca Saude reported revenue of $236M and EBITDA of $36M.
Allianca Saude expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $236M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $69M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA | — | XXX | $36M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Profit | — | XXX | ($25M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (11%) | XXX | XXX | XXX |
| Net Debt | — | — | $118M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Allianca Saude Stock Performance
Allianca Saude has current market cap of $160M, and enterprise value of $266M.
Market Cap Evolution
Allianca Saude's stock price is $1.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $266M | $160M | 37.7% | XXX | XXX | XXX | $-0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAllianca Saude Valuation Multiples
Allianca Saude trades at 1.1x EV/Revenue multiple, and 7.4x EV/EBITDA.
Allianca Saude Financial Valuation Multiples
As of April 4, 2026, Allianca Saude has market cap of $160M and EV of $266M.
Equity research analysts estimate Allianca Saude's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Allianca Saude has a P/E ratio of (6.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $160M | XXX | $160M | XXX | XXX | XXX |
| EV (current) | $266M | XXX | $266M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 7.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 12.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.8x | XXX | XXX | XXX |
| P/E | — | XXX | (6.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (9.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Allianca Saude Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Allianca Saude Margins & Growth Rates
Allianca Saude's revenue in the last fiscal year grew by 3%.
Allianca Saude Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 91% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 20% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Allianca Saude Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Devyser Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Nano X Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| Airdoc | XXX | XXX | XXX | XXX | XXX | XXX |
| EKF Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| MDxHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Allianca Saude M&A Activity
Allianca Saude acquired XXX companies to date.
Last acquisition by Allianca Saude was on XXXXXXXX, XXXXX. Allianca Saude acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Allianca Saude
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAllianca Saude Investment Activity
Allianca Saude invested in XXX companies to date.
Allianca Saude made its latest investment on XXXXXXXX, XXXXX. Allianca Saude invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Allianca Saude
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Allianca Saude
| When was Allianca Saude founded? | Allianca Saude was founded in 2011. |
| Where is Allianca Saude headquartered? | Allianca Saude is headquartered in Brazil. |
| Is Allianca Saude publicly listed? | Yes, Allianca Saude is a public company listed on B3. |
| What is the stock symbol of Allianca Saude? | Allianca Saude trades under AALR3 ticker. |
| When did Allianca Saude go public? | Allianca Saude went public in 2016. |
| Who are competitors of Allianca Saude? | Allianca Saude main competitors are Devyser Diagnostics, Nano X Imaging, Airdoc, EKF Diagnostics. |
| What is the current market cap of Allianca Saude? | Allianca Saude's current market cap is $160M. |
| What is the current revenue of Allianca Saude? | Allianca Saude's last fiscal year revenue is $236M. |
| What is the current EV/Revenue multiple of Allianca Saude? | Current revenue multiple of Allianca Saude is 1.1x. |
| Is Allianca Saude profitable? | No, Allianca Saude is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.